Orthofix Medical Inc.
OFIX
$12.31
$1.4613.46%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -10.21% | 9.69% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -10.21% | 9.69% | |||
| Cost of Revenue | 12.95% | 3.60% | |||
| Gross Profit | -19.93% | 12.47% | |||
| SG&A Expenses | -2.56% | 4.87% | |||
| Depreciation & Amortization | -30.02% | -4.61% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.98% | 4.62% | |||
| Operating Income | -341.42% | 54.28% | |||
| Income Before Tax | -75.47% | -11.54% | |||
| Income Tax Expenses | 270.39% | -175.10% | |||
| Earnings from Continuing Operations | -82.17% | -6.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -82.17% | -6.42% | |||
| EBIT | -341.42% | 54.28% | |||
| EBITDA | -92.25% | 13,968.09% | |||
| EPS Basic | -79.91% | -5.83% | |||
| Normalized Basic EPS | -44.56% | -3.07% | |||
| EPS Diluted | -79.91% | -5.83% | |||
| Normalized Diluted EPS | -44.56% | -3.07% | |||
| Average Basic Shares Outstanding | 1.26% | 0.55% | |||
| Average Diluted Shares Outstanding | 1.26% | 0.55% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||